T3D
0.16
300%
RKB
0.004
-55.6%
LKY
0.49
113%
HLX
0.001
-50%
ZNC
0.125
111.9%
KLR
0.275
-49.1%
IR1
0.16
72%
HFR
0.066
-40%
OLL
0.023
64.3%
OLH
0.015
-34.8%
AZI
0.035
59.1%
BP8
0.002
-33.3%
FUN
0.096
54.8%
CAE
0.028
-33.3%
SRL
2.9
45%
IFG
0.02
-33.3%
EVR
0.014
40%
JAV
0.002
-33.3%
SRJ
0.015
36.4%
M2R
0.002
-33.3%
LKO
1.75
35.7%
NEC
1.12
-32.5%
OSL
1.675
35.1%
SPX
0.005
-28.6%
NPM
0.027
35%
BGE
0.018
-28%
BML
0.28
33.3%
1TT
0.003
-25%
CTN
0.004
33.3%
4DS
0.009
-25%
D3E
0.5
33.3%
RNX
0.003
-25%
FAU
0.008
33.3%
4DX
1.76
-23.8%
TGM
0.24
33.3%
AGY
0.03
-23.1%
BSA
0.13
32.7%
EMU
0.018
-21.7%
MAT
0.13
32.7%
LU7
0.011
-21.4%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Imricor Medical Systems (ASX: IMR): Awarded CE mark approval

Developer of MRI-compatible devices, Imricor Medical Systems (ASX: IMR) has been awarded CE mark certification from the EU for its Vision-MR Diagnostic Catheter, allowing for manufacturing and release into the clinical market | ASX announcement: https://announcements.asx.com.au/asxpdf/20240306/pdf/0616gfxf12g8pc.pdf